BCEIE › News › IDEAFORGE

Order win

Ideaforge Technology wins order worth ₹23.62 crore

Ideaforge Technology (BSE: IDEAFORGE) said it has received an order valued at ₹23.62 crore. The company is valued at about ₹3,609 crore.

BCEIE News Desk · Published 30 Sept 2026, 03:19 pm IST · Filing received 30 Sept 2026, 03:03 pm IST

What happened

Ideaforge Technology (BSE: IDEAFORGE) informed the stock exchanges on 30 September 2026 at 03:03 PM that it has received an order valued at ₹23.62 crore.

How big is it?

At ₹23.62 crore, the order is equal to about 0.7% of the company's market value of ₹3,609 crore and 8.0% of its revenue over the last four reported quarters (₹295 crore).

Relative to the company's annual revenue, it is a modest addition.

Company snapshot

Ideaforge Technology is a small-cap company, with a market value of about ₹3,609 crore.

The stock last traded at ₹726.3, against a 52-week range of ₹366–₹992.3 (26.8% below the high).

Before this filing the shares had moved −9.5% over the month and −15.0% over three months. Average daily turnover over the last 20 sessions was about ₹17.59 crore.

Promoters held 25.26% at the end of Q2 FY27, down 3.70% points from the previous quarter; 2.95% of promoter shares were pledged. Foreign institutions owned 8.26% and domestic institutions 10.98%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY2613—-5.4
Q2 FY2654—-9.9
Q3 FY2632-33.9-7.75
Q4 FY261416013.72
Q1 FY2769-2.6-0.59

What history shows

BCEIE has no earlier order win filing from this company on record since May 2026.

Market-wide, 1,860 order win filings with an impact score of 50 or more saw an average next-day move of +0.8%, with 53% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Execution progress and revenue recognition from this order in the coming quarters.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.